Pharmaceuticals & Healthcare

Dr David Torstensson speaks on clinical trials transparency at American Chamber of Commerce to the EU in Brussels

Posted by:

Pugatch Consilium Partner, Dr Torstensson presented the main findings of the Pugatch Consilium report Heading in a Different Direction? The European Medicines Agency’s Policy on the Public Release of Clinical Trials Data at the report’s EU launch. The launch took place at the AmCham EU offices in Brussels, Belgium.

The report was commissioned by the US Chamber of Commerce’s GIPC. It examines the debate and policies in place on public disclosure of clinical trials data and information in Europe, the US, ...

Continue Reading →
0

When National Champions Fall

Posted by:

The case of Teva requires us to revise our thinking about national champions and national interests;
Prof. Meir Perez Pugatch addresses the current situation with Teva pharmaceuticals – the biggest generics company in the world – in Israel and how it has been impacted by the patent expiration of Copaxon. Full article at Pharmaphorum Media

Continue Reading →
0

Canada and the life sciences – thoughts on the future

Posted by:

This week, Pugatch Consilium’s Founder and MD, Professor Meir Pugatch, will be addressing a series of gatherings in Montreal and Ottawa to discuss the issue of competitiveness in the Canadian life sciences and, in particular, looking at the role of intellectual property protection in facilitating innovation. At the events, co-hosted by Montreal InVivo and Life Sciences Ontario, Professor Pugatch will outline his thoughts in front of an audience of distinguished guests including Canada’s minister of higher education, sciences and technology.

Drug ...

Continue Reading →
0

When is an incremental innovation not an incremental innovation?

Posted by:

The UK government recently announced that it would be offering all toddlers the flu vaccine as a nasal spray rather than as the traditional injection. All children aged two will be offered vaccination against flu, with the UK becoming the first country to offer the vaccine to healthy children free of charge. The new immunisation programme aims to give annual protection to 650,000 two-year-olds using a nasal spray called Fluenz.

As a mother, I was delighted to hear this news. As ...

Continue Reading →
0

Pugatch Consilium Launches New Paper on Clinical Trials

Posted by:

Pugatch Consilium launches new paper on Clinical trials and data transparency examining the public interest case for more pro-active release of clinical trials data and asking whether the benefits to public welfare are outweighed by the hurdles of bureaucracy, patient privacy and concerns over protection of IPRs and commercial confidentiality. Download a copy from the Research & Analysis Reports page.

Continue Reading →
0
Page 4 of 6 «...23456